SHIFT Newsroom · GLOBAL
Trial record: tirzepatide for binge-eating disorder
Registry status checked on 3 October 2026: recruiting.
ClinicalTrials.gov lists NCT06847399, concerning tirzepatide for binge-eating disorder, as recruiting. The record was first posted on 2025-02-26 and last updated on 2026-09-09; SHIFT checked it on 3 October 2026.
The research question concerns binge-eating disorder. A trial in this indication does not erase the medicine’s existing product information or establish a new authorised use.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.
